99 related articles for article (PubMed ID: 10437918)
1. The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin.
Louro ID; McKie-Bell P; Gosnell H; Brindley BC; Bucy RP; Ruppert JM
Cell Growth Differ; 1999 Jul; 10(7):503-16. PubMed ID: 10437918
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.
Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T
Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403
[TBL] [Abstract][Full Text] [Related]
3. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
[TBL] [Abstract][Full Text] [Related]
4. Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation.
Louro ID; Bailey EC; Li X; South LS; McKie-Bell PR; Yoder BK; Huang CC; Johnson MR; Hill AE; Johnson RL; Ruppert JM
Cancer Res; 2002 Oct; 62(20):5867-73. PubMed ID: 12384550
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of resistance to rapamycin in human cancer cells.
Hosoi H; Dilling MB; Liu LN; Danks MK; Shikata T; Sekulic A; Abraham RT; Lawrence JC; Houghton PJ
Mol Pharmacol; 1998 Nov; 54(5):815-24. PubMed ID: 9804616
[TBL] [Abstract][Full Text] [Related]
6. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
Tirado OM; Mateo-Lozano S; Notario V
Oncogene; 2005 May; 24(20):3348-57. PubMed ID: 15782132
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
Hosoi H; Dilling MB; Shikata T; Liu LN; Shu L; Ashmun RA; Germain GS; Abraham RT; Houghton PJ
Cancer Res; 1999 Feb; 59(4):886-94. PubMed ID: 10029080
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
[TBL] [Abstract][Full Text] [Related]
11. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
12. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF.
Foster KW; Ren S; Louro ID; Lobo-Ruppert SM; McKie-Bell P; Grizzle W; Hayes MR; Broker TR; Chow LT; Ruppert JM
Cell Growth Differ; 1999 Jun; 10(6):423-34. PubMed ID: 10392904
[TBL] [Abstract][Full Text] [Related]
13. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
14. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin resistance in ataxia-telangiectasia.
Beamish H; Williams R; Chen P; Khanna KK; Hobson K; Watters D; Shiloh Y; Lavin M
Oncogene; 1996 Sep; 13(5):963-70. PubMed ID: 8806686
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A and rapamycin regulate the nuclear localization and activity of the transcription factor GLI3.
Krauss S; Foerster J; Schneider R; Schweiger S
Cancer Res; 2008 Jun; 68(12):4658-65. PubMed ID: 18559511
[TBL] [Abstract][Full Text] [Related]
17. Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.
Werzowa J; Koehrer S; Strommer S; Cejka D; Fuereder T; Zebedin E; Wacheck V
J Invest Dermatol; 2011 Feb; 131(2):495-503. PubMed ID: 21048785
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
[TBL] [Abstract][Full Text] [Related]
19. The works of GLI and the power of hedgehog.
Ruiz i Altaba A
Nat Cell Biol; 1999 Oct; 1(6):E147-8. PubMed ID: 10559974
[No Abstract] [Full Text] [Related]
20. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
Ma PC; Schaefer E; Christensen JG; Salgia R
Clin Cancer Res; 2005 Mar; 11(6):2312-9. PubMed ID: 15788682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]